Mayo Clinic is conducting a clinical trial to look at CBD’s effects on stomach function.
The study will focus on:
Dyspepsia (an upset stomach caused by malfunctioning muscles and/or nerves); and
Gastroparesis (a paralyzed stomach).
CBD will be administered orally until the target dose of 20mg/kg is reached.
Recruiting is expected to begin in September 2019.
Study results are expected to be available in 2024.